RAPT THERAPEUTICS INC (RAPT)
US75382E1091 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 47.48M | 38.90M | 24.00M | 24.90M | 77.40M | |||
| Marketable Securities | 111.38M | 210.10M | 165.60M | 86.60M | N/A | |||
| Other Current Assets | 2.92M | 3.60M | 3.30M | 4.10M | 3.10M | |||
| Total Current Assets | 161.78M | 252.70M | 193.00M | 115.60M | 80.50M | |||
| Non-Current Assets | ||||||||
| PPE Net | 7.68M | 9.50M | 2.70M | 3.00M | 3.70M | |||
| Other Non-Current Assets | 3.87M | 4.00M | 2.90M | 400.00K | 400.00K | |||
| Total Non-Current Assets | 11.55M | 13.50M | 5.60M | 3.40M | 4.10M | |||
| TOTAL ASSETS | 173.33M | 266.20M | 198.60M | 119.00M | 84.60M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 16.55M | 10.80M | 6.30M | 4.90M | 3.60M | |||
| Accounts Payable | 5.18M | 3.40M | 2.00M | 2.40M | 1.10M | |||
| Other Current Liabilities | 109.00K | 0.00 | 1.30M | 4.40M | 4.50M | |||
| Total Current Liabilities | 21.84M | 14.20M | 9.60M | 11.70M | 9.30M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 4.46M | 6.80M | 2.70M | 3.00M | 2.20M | |||
| Total Non-Current Liabilities | 4.46M | 6.80M | 2.70M | 3.10M | 2.20M | |||
| TOTAL LIABILITIES | 26.29M | 21.00M | 12.30M | 14.80M | 11.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -484.68M | -367.90M | -284.00M | -214.80M | -162.00M | |||
| Additional Paid In Capital | 631.61M | 613.10M | 470.60M | 319.20M | 235.00M | |||
| Common Shares | 3.00K | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 103.00K | 0.00 | -200.00K | -200.00K | 0.00 | |||
| Shares Outstanding | 34.40M | 34.30M | 29.60M | 24.80M | 21.80M | |||
| Tangible Book Value per Share | 4.27 | 7.15 | 6.30 | 4.20 | 3.35 | |||
| Total Shareholders' Equity | 147.03M | 245.20M | 186.40M | 104.20M | 73.10M | |||
| TOTAL LIABILITIES AND EQUITY | 173.33M | 266.20M | 198.60M | 119.00M | 84.60M | |||
| Statistics | ||||||||
| Current Ratio | 7.41 | 17.80 | 20.10 | 9.88 | 8.66 | |||
| Return On Assets (ROA) | -67.39% | -31.50% | -34.84% | -44.45% | -50.83% | |||
| Return On Equity (ROE) | -79.44% | -34.19% | -37.12% | -50.76% | -58.82% | |||
All data in USD